Prof. Dr.
Şefik İĞDEM

Prof. Dr.
Şefik İĞDEM

Randevu Al
Gayrettepe Florence Nightingale Hastanesi
Özel İlgi Alanları
  • Prostat Kanseri
  • Baş - Boyun Kanserleri
  • Radyasyon Onkolojisi

    • 2016
      T.C. Demiroğlu Bilim Üniversitesi 
      Profesör

      2011
      T.C. Demiroğlu Bilim Üniversitesi
      Doçent 

      1998
      Gayrettepe Florence Nightingale Hastanesi
      Radyasyon Onkolojisi

      1996
      İ.Ü. Cerrahpaşa Tıp Fakültesi
      Radyasyon Onkolojisi Uzmanlık Eğitimi 

      1991
      İstanbul Üniversitesi Tıp Fakültesi
      Tıp Eğitimi

      • ASTRO
      • ESTRO
      • Türk Radyasyon Onkolojisi Derneği 

  • Uluslararası Hakemli Dergilerde Yayımlanan Makaleler

      •  1.(SCI & SSCI & Arts and Humanities) DC Weber, RC Miller, S. Villa, P.Hanssens, BG Baumert, P.Cadtadot, P.Varlet, U.Abacıoğlu, 
      • 2.S.İğdem, E.Szutowicz, H.Nishioka, S.Hofer, HP Rutz, M.Özşahin, A.Taghian, RO Mirimanof. 
      • Outcome and prognostic factors in cerebellar glioblastoma multiforme in adults: a retrospective 
      • study from Rare Cancer Network. Int J Radiat Oncol Biol Phys 2006; 66:179-186 
      • Demiral AN, Alıcıkuş ZA, Uğur VI, Karadoğan İ, Yöney A, Andrieu MN, Yalman D, Pak Y, Aksu 
      • G, Özyiğit G, Özkan L, Kılçıksız S, Koca S, Çaloğlu M, Yavuz AA, Çağlar HB, Beyzadeoğlu M, 
      • 3.İğdem Ş, Serin M, Kaplan B, Koç M, Korkmaz E, Karakoyun-Çelik Ö, Dinçer S, Kınay M.
      • Patterns of care for lung cancer in radiation oncology clinics of Turkey. Int J Radiat Oncol Biol 
      • Phys 2008;72:1530-15 
      • 4.İğdem Ş, Okkan S, Ünalan B, İğdem AA, Ferhanoğlu B. Cervical cancer coexisting with small 
      • lymphocytic lymphoma detected during positron emission tomography/computed tomography 
      • simulation: A case report. Eur J Gynaec Oncol 2008; 4: 405-407 
      • 5.İğdem Ş, Ercan T, Alço G, Zengin F, Özgüleş R, Geceer G, Okkan S, Öber A, Turkan S. 
      • Dosimetric comparison of intensity modulated pelvic radiotherapy with 3D conformal radiotherapy 
      • in patients with gynecologic malignancies. Eur J Gynaec Oncol 2009; 5:547-551 
      • 6.İğdem Ş, Akpınar H, Alço G, Ağaçayak F, Turkan S, Okkan S. Implantation of fiducial markers for 
      • image guidance in prostate radiotherapy: patient-reported toxicity. Br J Radiol 2009; 82:941-945 
      • 7.İğdem Ş, Alço G, Ercan T, Barlan M, Ganiyusufoğlu K, Ünalan B, Turkan S, Okkan S. 
      • Insufficiency fractures after pelvic radiotherapy in patients with prostate cancer. Int J Radiat Oncol 
      • Biol Phys 2010;77:818-823
      • 8.İğdem Ş, Abacıoğlu U, Çetin İ, Alço G, Akgün Z, Şengöz M, Bekiroğlu N, Turkan S, Okkan S. 
      • Impact of Percent Positive Random Biopsies on Biochemical Outcome in Prostate Cancer Patients 
      • Treated with External Beam Radiotherapy With or Without Androgen Deprivation. J.BUON 
      • 2009;14:629-634 
      • 9.Alço G, İğdem Ş, Dinçer M, Tecimer C, Şentürk R, Vural M, Okkan S. Gemcitabine induced 
      • radiation recall myositis: Report of two cases and review of the literature. UHOD 2009;19:249-253 
      • 10.Alço.G, İğdem Ş, Ercan T, Dinçer M, Şentürk R, Atilla S, Zengin F, Okkan S. Coverage of axillary 
      • lymph nodes with high tangential fields in breast radiotherapy. The British Journal of Radiology 
      • 2010; 83:1072-1076 
      • Feldman-Stewart D, Capirci C, Brennenstuhl S, Tong C, Abacıoğlu U, Gawkowska-Suwinska M, 
      • van Gils F, Heyda A, İğdem S, Macias V, Grillo IM, Pijls-Johannesma M, Parker C, Pimentel N, 
      • Wördehoff H. Information needs of early stage prostate cancer patients: A comparison of nine 
      • countries. Radiotherapy and Oncology. 2010; 94:328-333
      • 11.İğdem Ş, Alço G, Ercan T, Ünalan B, Kara B, Geceer G, Akman C, Zengin FO, Atilla S, Okkan S. 
      • The application of positron emission tomography/computed tomography in radiation treatment 
      • planning: Effect on gross target volume definition and treatment management. Clinical Oncology 
      • 2010;22:173-178
      • 12.İğdem Ş, Spiegel DY, Efstathiou J, Miller RC, Poortmans PMP, Koca S, Kılıç-Ünsal D, Okkan S, 
      • Zietman A. Prostatic Duct adenocarcinoma: Clinical characteristics, Treatment options, and 
      • Outcomes- a Rare Cancer Network study. Onkologie. 2010;33:169-173
      • 13.Ercan T, İğdem Ş, Alço G, Zengin F, Atilla S, Dinçer M, Okkan S. Dosimetric comparison of field-
      • in-field intensity modulated radiotherapy technique with conformal radiotherapy techniques in 
      • breast cancer. Jpn J Radiol 2010;28:283-289
      • 14.Önal C, Li XY, Miller RC, Poortmans PMP, Constantinou N, Weber DC, Atasoy BM, İğdem Ş, 
      • Özşahin M, Özyar E. Treatment results and prognostic factors in primary throid lymphoma patients: 
      • a Rare Cancer Network study. Ann Oncol. 2011;22(1):156-64 

Sağlık Rehberi İçerikleri